BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Vijaya Diagnostic Centre Ltd.’s Q4 FY23 performance was driven by a steady 22.4% YoY growth in non-Covid business, while Covid business’ contribution fell to 1% (15% in Q4 FY22).
Overheads of new centres impacted Ebitda margin to a small extent though, at 40.6% in Q4, it continues to be better than that of most of listed peers. Strong business-to-consumer franchise (95% of revenue in Q4 FY23) and a dominant presence in radiology has helped Vijaya Diagnostic command better margins.
Traction in new centres at Tirupati and Rajamundhry, coupled with further expansion in the east (especially Kolkata), may drive medium- to long-term growth.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
Gravita India - A Capex, ESG Play; ICICI Securities Initiates Coverage With A Buy
May 09, 2024
Go Fashion Q4 Results Review - Demand Outlook Remains Challenging: ICICI Securities
May 06, 2024
Covid Patient Dies After Record 613-Day Infection Spawned New Mutations
Apr 19, 2024
Greaves Electric Mobility Appoints K Vijaya Kumar As Executive Director & CEO
Apr 05, 2024
POPULAR